RecruitingNot applicableNCT06648044

Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies

Studying Autosomal dominant tubulointerstitial kidney disease

Last synced from ClinicalTrials.gov May 13, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Imagine Institute
Intervention: Description: Research of therapeutic targets in the frame of nephronophthisis and renal associated ciliopathie(other)
Enrollment: 310 enrolled
Eligibility: All sexes
Timeline: 2016 – 2028

Study locations (1)

Imagine Institute, La Defense, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06648044 on ClinicalTrials.gov

Other trials for Autosomal dominant tubulointerstitial kidney disease

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT04819217
Study of Oral Uremic Toxin Absorbent and Probiotics to Retard the Progression of Chronic Kidney Disease
National Taiwan University Hospital

See all trials for Autosomal dominant tubulointerstitial kidney disease →

← Back to all trials